The a2 Milk Co Ltd (ASX: A2M) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

The a2 Milk Co Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $3.95 billion
P/E Ratio 23.05
Dividend Yield 0.00%
Shares Outstanding 724.02 million
Earnings per share 0.231
Dividend per share N/A
Year To Date Return 12.91%
Earnings Yield 4.34%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • The a2 Milk Co Ltd (ASX: A2M)
    Latest News

    Transurban share price ASX shares upgrade to buy asx 200 share price upgrade to buy represented by hand drawing line under the word upgrade
    Cheap Shares

    Leading brokers just upgraded these ASX shares to "buy" today

    The market may be giving ground this morning but two ASX shares are bucking the downtrend after getting upgraded to…

    Read more »

    Young man looking afraid representing ASX shares investor scared of market crash
    Share Market News

    Share market on watch over AstraZeneca vaccine fears

    The AstraZeneca vaccine has been suspended from use by at least 16 nations. What impact, if any, could this have…

    Read more »

    China factory worker giving thumbs up
    Share Market News

    Chinese factory output is up an astonishing 35%

    Reuters reported output in China was up 35.1% in the January/February period compared to a year earlier. How does this…

    Read more »

    Ethical investor and fund manager Jon Fernie
    Ask a Fund Manager

    This fundie refuses to invest in gambling and fossil fuels

    Ask A Fund Manager: U Ethical's Jon Fernie tells how you can make money while still remaining faithful to your…

    Read more »

    Golden retriever dog holding a newspaper in its mouth
    Share Market News

    ASX 200 Weekly Wrap: Calm restored to the ASX 200

    Here on our ASX 200 Foolish Weekly Wrap, we look at the things that moved the S&P/ASX 200 Index and…

    Read more »

    Red wall with large white exclamation mark leaning against it
    Share Fallers

    These were the worst performing ASX 200 shares last week

    A2 Milk Company Ltd (ASX:A2M) and Zip Co Ltd (ASX:Z1P) were among the worst performers on the ASX 200 last…

    Read more »

    ⏸️ ASX Shares

    Is it time to buy at this A2 Milk (ASX:A2M) share price?

    The A2 Milk Company Ltd (ASX:A2M) share price has continued to drop. Could it be time to jump on shares…

    Read more »

    A teacher in front of a classroom chalkboard filled with questionmarks, indicating share market uncertainty
    Share Market News

    Where next for the A2 Milk (ASX:A2M) share price?

    The A2 Milk Company Ltd (ASX:A2M) share price is down 42% over the last 12 months. Where are a2 Milk's…

    Read more »

    a woman holds her hand to her chin and looks skywards while she is thinking against a backdrop of graphic question marks
    How to invest

    Here's why you should think twice about chasing the next hot ASX trend

    Looking to find the next Amazon (AMZN) or A2 Milk (A2M)? Here's why finding a 10-bagger trend is even harder…

    Read more »

    Young Female investor gazes out window at cityscape
    Share Market News

    International Women's Day: Which ASX companies are fighting gender inequality?

    On International Women's Day 2021, we're diving deep to look at gender bias within companies listed on the Australian Stock…

    Read more »

    Share Market News

    Top brokers name 3 ASX shares to buy next week

    Top brokers have named A2 Milk Company Ltd (ASX:A2M) and these ASX shares as buys for next week. Here's why…

    Read more »

    baby with look of surprised as if at huge increase in COVID baby boom asx shares
    Share Market News

    Synlait (ASX:SM1) share price crashes 7% on cancelled guidance

    The Synlait (ASX:SM1) share price is sliding in early trade after the dairy producer withdrew its FY21 profit guidance. Here's…

    Read more »

    Frequently Asked Questions

    The a2 Milk Company Ltd does not currently pay a dividend.

    The a2 Milk Company Ltd does not currently have a dividend reinvestment program.

    The company was founded in 2000 in New Zealand and listed on the ASX in March 2015.

    A2M ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About The a2 Milk Co Ltd

    A2 Milk Company Ltd (ASX: A2M) is a fresh milk and infant formula company that sources, produces and supplies a2 brand milk and milk-related products in Australia and globally.

    The Company was founded in 2000 in New Zealand by scientist Dr Corran McLachlan and Howard Paterson.

    The company produces fresh cows' milk that naturally contains the A2 protein type and no A1 protein. Some research suggests the A1 protein can cause digestion issues.

    A2M Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    22 Nov 2024 $5.45 $0.64 13.31% 10,716,572 $5.59 $5.72 $5.38
    21 Nov 2024 $4.81 $-0.05 -1.03% 1,965,985 $4.88 $4.88 $4.81
    20 Nov 2024 $4.86 $-0.05 -1.02% 1,458,109 $4.92 $4.93 $4.82
    19 Nov 2024 $4.91 $-0.01 -0.20% 1,127,277 $4.93 $4.96 $4.89
    18 Nov 2024 $4.92 $0.11 2.29% 2,061,480 $4.82 $4.94 $4.79
    15 Nov 2024 $4.81 $-0.09 -1.84% 1,855,320 $4.92 $4.95 $4.80
    14 Nov 2024 $4.90 $0.12 2.51% 2,529,308 $4.78 $4.90 $4.76
    13 Nov 2024 $4.78 $-0.04 -0.83% 3,425,795 $4.80 $4.87 $4.73
    12 Nov 2024 $4.82 $-0.10 -2.03% 6,595,003 $4.95 $4.95 $4.77
    11 Nov 2024 $4.92 $-0.36 -6.82% 5,608,810 $5.30 $5.30 $4.89
    08 Nov 2024 $5.28 $0.09 1.73% 3,614,439 $5.23 $5.29 $5.14
    07 Nov 2024 $5.19 $-0.13 -2.44% 4,171,502 $5.26 $5.29 $5.19
    06 Nov 2024 $5.32 $-0.16 -2.92% 2,402,885 $5.46 $5.50 $5.32
    05 Nov 2024 $5.48 $-0.11 -1.97% 2,911,127 $5.56 $5.57 $5.39
    04 Nov 2024 $5.59 $-0.12 -2.10% 2,148,664 $5.70 $5.71 $5.56
    01 Nov 2024 $5.71 $-0.06 -1.04% 1,122,735 $5.70 $5.78 $5.69
    31 Oct 2024 $5.77 $0.02 0.35% 1,983,122 $5.73 $5.84 $5.68
    30 Oct 2024 $5.75 $-0.08 -1.37% 1,646,474 $5.90 $5.91 $5.75
    29 Oct 2024 $5.83 $0.10 1.75% 5,071,981 $5.79 $5.98 $5.78
    28 Oct 2024 $5.73 $-0.01 -0.17% 1,772,557 $5.74 $5.78 $5.70
    25 Oct 2024 $5.74 $-0.07 -1.20% 2,052,391 $5.81 $5.83 $5.73

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    30 Aug 2024 David Bortolussi Buy 490,906 $2,744,164
    Conversion of securities.
    30 Aug 2024 David Bortolussi Exercise 490,906 $2,744,164
    Conversion of securities. 1,191,246 performance rights
    15 Dec 2023 David Bortolussi Issued 690,066 $2,794,767
    Issue of securities. 1,682,152 performance rights

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Warwick Lynton Every-Burns Non-Executive Director Aug 2016
    Mr Every-Burns has been a career Consumer Packaged Goods (CPG) executive of global scale. His executive roles have included a career with The Clorox Company of the USA as Senior Vice President, International, based in the USA and prior to that as VP Asia Pacific. His earlier roles included Managing Director of NationalPak Limited (the Glad Products Company ultimately acquired by Clorox) and a long career with Unilever plc where he was based in Australia. He is also Chair of the People and Remuneration Committee.
    Mr David Landt Bortolussi Chief Executive OfficerManaging Director Feb 2021
    Mr Bortolussi career has been focused on the consumer and retail sector in Australia and New Zealand complemented by international experience in various markets and categories in China, SE Asia, the EU and the USA. David also has an interest in private equity and growth-phase businesses. He is a member of the advisory board of Whiteoak and supports the development of investee companies.
    Ms Philippa (Pip) Mary Greenwood Non-Executive Director Jul 2019
    Ms Greenwood is also the Chair of Westpac New Zealand and a director of Fisher & Paykel Healthcare. She was previously a director of Spark New Zealand and Vulcan Steel. Prior to becoming a full-time director, Pip was a senior partner at law firm Russell McVeagh, where she spent over 10 years on the firm's Board including acting as the firm's Board Chair and interim CEO.
    Ms Kathryn(Kate) Mitchell Non-Executive Director Jun 2023
    Ms Mitchell has governance experience as a director of both private and public companies. Prior to moving to New Zealand in 2014, Kate's executive career spanned over 20 years in investment banking in London, which included senior leadership roles in the Global Markets division within investment banks including Deutsche Bank, Goldman Sachs and Merrill Lynch. She also has experience in developing solutions for clients, particularly in the areas of financial risk management, structured financing and investments. She is also Chair of the Risk Management Committee.
    Ms Sandra Yu Non-Executive Director Mar 2022
    Ms Yu is a company director and a global executive in consumer goods industries, and importantly in the infant milk formula (IMF) market in China, with a proven track record of driving business and brand transformation, leveraging opportunities for growth, and building organizational capabilities across China as well as the USA and other parts of Asia. Prior to that, Sandra held various other senior executive roles at Mead Johnson Nutrition, including as the Global Marketing Vice President, responsible for transition to new digital media and e-commerce channels globally.
    Mr David Wang Non-Executive Director Sep 2022
    Mr Wang brings expertise across the Asia-Pacific region in manufacturing and supply chain with over 30 years of experience in industrial and consumer goods businesses including 15 years in senior executive leadership roles in China and international. In his career, David has held various senior executive roles including at Blackstone AVINTIV Inc and Dover Corporation where his responsibilities covered manufacturing, research and development, technology, sales and marketing throughout Asia. David sits on both the Risk Management and the People and Remuneration Committees.
    Mr Antonio (Tonet) Rivera Non-Executive Director Nov 2024
    Mr Rivera has over 35 years of supply chain experience, including 17 years of international leadership experience. Mr Rivera worked for Mead Johnson Nutrition from 2002 to 2017, in four years leading the global supply chain of the multinational nutrition company in the role of Senior Vice President, Global Supply Chain. Prior to that, he served as Vice President, Supply Chain - Asia and Europe for more than a decade, with responsibility for Supply Chain operations in Europe and Asia, including owned manufacturing locations and third-party manufacturers. Since retiring from executive roles in 2017, when Mead Johnson Nutrition was acquired by Reckitt Benckiser Group plc, Mr Rivera has worked as a supply chain consultant.
    Mr Jaron McVicar Company SecretaryGeneral Counsel Nov 2016
    -
    Jaron McVicar Company SecretaryGeneral Counsel
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 113,290,528 15.67%
    Citicorp Nominees Pty Limited 96,163,814 13.30%
    BNP Paribas Nominees NZ Limited Bpss40* 42,529,528 5.88%
    J P Morgan Nominees Australia Pty Limited 34,661,044 4.79%
    HSBC Nominees (New Zealand) Limited* 26,156,306 3.62%
    Tea Custodians Limited* 21,013,734 2.91%
    HSBC Custody Nominees (Australia) Limited Gsco Eca 20,980,543 2.90%
    Accident Compensation Corporation* 20,509,205 2.84%
    JPMORGAN Chase Bank* 18,595,095 2.57%
    New Zealand Superannuation Fund Nominees Limited* 17,659,815 2.44%
    Citibank Nominees (NZ) Ltd* 15,787,511 2.18%
    New Zealand Depository Nominee 14,021,429 1.94%
    National Nominees Limited 13,425,469 1.86%
    HSBC Nominees (New Zealand) Limited* i 9,463,432 1.31%
    Premier Nominees Limited* 8,473,699 1.17%
    Public Trust* 7,323,398 1.01%
    UBS Nominees Pty Ltd 6,938,917 0.96%
    New Zealand Permanent Trustees Limited* 6,325,699 0.88%
    BNP Paribas Noms Pty Ltd 6,123,304 0.85%
    JBWere (NZ) Nominees Limited 5,945,531 0.82%

    Profile

    since

    Note